Latest filing published 29 May 2026 for Gentian Diagnostics ASA, €17k.
Insider track record
No signal scores available.
Matti Heinonen: trading record in brief
Matti Heinonen discloses dealings in Gentian Diagnostics ASA to Oslo Børs. Between 16 December 2024 and 29 May 2026, the trades on record add up to 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 29 May 2026: a transaction of €17k, in Gentian Diagnostics ASA. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Companies and markets linked to Matti Heinonen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ NOK 35.8533.9% of flowOptionXOSLOSLO:674916
- 2,500 shares@ NOK 40.0018.0% of flowOptionXOSLOSLO:665812
- 5,000 shares@ NOK 54.8648.1% of flowOptionXOSLOSLO:658078
- @ €5.3446OptionXOSLOSLO:634851
4 of 4 declarations